Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Revance Therapeutics Inc.

    NASDAQ: RVNC · Real-Time Price · USD
    3.65
    0.00 (0.00%)
    At close: Feb 05, 2025, 3:59 PM

    Revance Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 234.04M 132.56M 77.8M
    Cost of Revenue
    		 152.16M 51.67M 23.41M
    Gross Profit
    		 81.88M 80.9M 54.39M
    Operating Income
    		 -316.78M -272.17M -274.68M
    Interest Income
    		 13.29M 4.89M 337K
    Pretax Income
    		 -323.69M -355.72M -281.31M
    Net Income
    		 -323.99M -356.42M -286.82M
    Selling & General & Admin
    		 292.24M 219.7M 198.82M
    Research & Development
    		 79.41M 101.29M 116.25M
    Other Expenses
    		 27.01M 27.85M 13.99M
    Operating Expenses
    		 398.65M 353.07M 329.06M
    Interest Expense
    		 19.36M 16.47M 6.27M
    Selling & Marketing Expenses
    		 253.42M 183.1M 6.2M
    Cost & Expenses
    		 550.82M 404.73M 352.47M
    Income Tax Expense
    		 300K 700K 5.51M
    Shares Outstanding (Basic)
    		 84.6M 72.71M 67.51M
    Shares Outstanding (Diluted)
    		 84.6M 72.71M 67.51M
    EPS (Basic)
    		 -3.83 -4.9 -4.25
    EPS (Diluted)
    		 -3.83 -4.9 -4.25
    EBITDA
    		 -290.64M -305.52M -255.18M
    EBIT
    		 -304.33M -339.25M -275.04M
    Depreciation & Amortization
    		 13.69M 33.73M 19.85M

    Add to Watchlist